Marker predicting liver cancer recurrence in patients with liver transplantation prescription and uses thereof

摘要

The present invention relates to a marker for predicting the prognosis of liver cancer recurrence in liver cancer patients, and more specifically, an RNA marker related to the amount of immunoregulatory cells for suppressing the inflammatory response and inflammatory response appearing in liver transplantation surgery patients or preliminary liver transplantation patient groups. It relates to use as a marker for predicting relapse prognosis. The present inventors found a change in the expression pattern of a gene related to liver cancer recurrence in a patient who was prescribed liver transplantation surgery, and found that the gene can be a predictive marker for liver cancer recurrence prognosis. The marker according to the present invention is a liver transplantation It is expected that it will help the management and treatment of liver cancer patients who have been prescribed this by predicting the recurrence of liver cancer.